Sentrx Growth Continues with Four New Clients in Second Quarter (2008-07-30)
Sentrx, a leading provider of drug safety services, gained four new contracts in the second quarter, including a risk evaluation and mitigation strategy (REMS). The company was also awarded a significant contract expansion.
Sentrx Growth Continues with Four New Clients in Second Quarter (2008-07-30)
Sentrx, a leading provider of drug safety services, gained four new contracts in the second quarter, including a risk evaluation and mitigation strategy (REMS). The company was also awarded a significant contract expansion.
Amrit Ray, VP at BMS to speak at Global Clinical Trial Operations Conf, 9/25-26 in San Diego (2008-06-16)
Amrit Ray, Vice President of Bristol-Myers Squibb will give the keynote presentation at GTCbio’s Global Clinical Trial Operations conference on September 25-26, 2008 in San Diego, CA. Dr. Ray will give a presentation entitled “The Next Generation of Pharmacovigilance - Clinical Trials and Drug Development in the New Era of Drug Safety.”